NCT02826005
Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.
Phase: N/A
Role: Lead Sponsor
Start: Jul 31, 2016
Completion: Aug 31, 2017